IRS approves pension plan substitute mortality tables
Apply this to your situation
This page covers one taxpayer's ruling from 2021, which can't be cited as precedent. Ezel answers your situation under the current Code and IRS guidance, with citations.
Plain-English summary
A single-employer defined benefit pension plan asked to use plan-specific substitute mortality tables for its funding calculations under Section 430. The IRS approved substitute tables for male and female annuitants, excluding disabled annuitants, for up to five plan years. Male and female nonannuitants had insufficient credible mortality experience, so the plan had to use the standard tables for those populations. The approved rates must be applied on a generational basis and can terminate early if credibility, controlled-group, population-change, predictive-accuracy, or replacement-table conditions arise. The plan must monitor its populations, provide required actuarial certifications and supporting data, and use the standard tables if it misses the reporting deadline.
Ruling snapshot
- Question: Could the pension plan use substitute mortality tables for specified participant populations in its Section 430 funding calculations?
- Outcome: Approved for male and female annuitants, excluding disabled annuitants; standard tables remained required for nonannuitants.
- Key authorities: IRC § 430(h)(3); ERISA § 303(h)(3); Treas. Reg. §§ 1.430(h)(3)-1 and 1.430(h)(3)-2; Rev. Proc. 2017-55
Full text (IRS public release)
Significant Index No. 0430.00-00
DEPARTMENT OF THE TREASURY
INTERNAL REVENUE SERVICE
WASHINGTON, D.C. 20224
TAX EXEMPT AND
GOVERNMENT ENTITIES
DIVISION
APR 19 2021
Number: 202128008
Release Date: 7/16/2021
Re:
Taxpayer = [redacted]
Plan for which substitute mortality tables are requested:
Plan = [redacted]
EIN: [redacted]; (Plan No. [redacted])
Dear [redacted]:
This letter is to inform you that your request to use substitute mortality tables for making
computations under section 430 of the Internal Revenue Code (the “Code”) for the
above Plan has been granted with respect to the populations specified in this letter. This
ruling is effective for a period of up to 5 plan years beginning with the plan year
commencing January 1, [redacted]. Your request has been granted in accordance with
section 430(h)(3) of the Code and section 303(h)(3) of the Employee Retirement
Income Security Act of 1974.
This approval applies to the following specific populations:
- Male annuitants (excluding disabled annuitants)
- Female annuitants (excluding disabled annuitants)
Based on the information provided by the Taxpayer, the following populations do not
have credible mortality experience, and therefore the standard mortality tables will be
used for calculations under section 430 of the Code:
- Male nonannuitants
- Female nonannuitants
In granting this approval, we have only considered whether the substitute mortality rates
were developed in accordance with section 1.430(h)(3)-2 of the Treasury Regulations
(“Regulations”) and Revenue Procedure 2017-55. Accordingly, we are not expressing
any opinion as to the accuracy or acceptability of any calculations or other material
submitted with your request.
2
Permission is hereby granted to use the substitute mortality rates shown in the table
below for the Plan:
Substitute Mortality Tables
Approved for use beginning with the plan year commencing January 1, [redacted]
Base year [redacted]
| Age | Male Annuitants | Female Annuitants |
|---|---|---|
| 0 | [redacted] | [redacted] |
| 1 | [redacted] | [redacted] |
| 2 | [redacted] | [redacted] |
| 3 | [redacted] | [redacted] |
| 4 | [redacted] | [redacted] |
| 5 | [redacted] | [redacted] |
| 6 | [redacted] | [redacted] |
| 7 | [redacted] | [redacted] |
| 8 | [redacted] | [redacted] |
| 9 | [redacted] | [redacted] |
| 10 | [redacted] | [redacted] |
| 11 | [redacted] | [redacted] |
| 12 | [redacted] | [redacted] |
| 13 | [redacted] | [redacted] |
| 14 | [redacted] | [redacted] |
| 15 | [redacted] | [redacted] |
| 16 | [redacted] | [redacted] |
| 17 | [redacted] | [redacted] |
| 18 | [redacted] | [redacted] |
| 19 | [redacted] | [redacted] |
| 20 | [redacted] | [redacted] |
| 21 | [redacted] | [redacted] |
| 22 | [redacted] | [redacted] |
| 23 | [redacted] | [redacted] |
| 24 | [redacted] | [redacted] |
| 25 | [redacted] | [redacted] |
| 26 | [redacted] | [redacted] |
| 27 | [redacted] | [redacted] |
| 28 | [redacted] | [redacted] |
| 29 | [redacted] | [redacted] |
| 30 | [redacted] | [redacted] |
| 31 | [redacted] | [redacted] |
| 32 | [redacted] | [redacted] |
3
| Age | Male Annuitants | Female Annuitants |
|---|---|---|
| 33 | [redacted] | [redacted] |
| 34 | [redacted] | [redacted] |
| 35 | [redacted] | [redacted] |
| 36 | [redacted] | [redacted] |
| 37 | [redacted] | [redacted] |
| 38 | [redacted] | [redacted] |
| 39 | [redacted] | [redacted] |
| 40 | [redacted] | [redacted] |
| 41 | [redacted] | [redacted] |
| 42 | [redacted] | [redacted] |
| 43 | [redacted] | [redacted] |
| 44 | [redacted] | [redacted] |
| 45 | [redacted] | [redacted] |
| 46 | [redacted] | [redacted] |
| 47 | [redacted] | [redacted] |
| 48 | [redacted] | [redacted] |
| 49 | [redacted] | [redacted] |
| 50 | [redacted] | [redacted] |
| 51 | [redacted] | [redacted] |
| 52 | [redacted] | [redacted] |
| 53 | [redacted] | [redacted] |
| 54 | [redacted] | [redacted] |
| 55 | [redacted] | [redacted] |
| 56 | [redacted] | [redacted] |
| 57 | [redacted] | [redacted] |
| 58 | [redacted] | [redacted] |
| 59 | [redacted] | [redacted] |
| 60 | [redacted] | [redacted] |
| 61 | [redacted] | [redacted] |
| 62 | [redacted] | [redacted] |
| 63 | [redacted] | [redacted] |
| 64 | [redacted] | [redacted] |
| 65 | [redacted] | [redacted] |
| 66 | [redacted] | [redacted] |
| 67 | [redacted] | [redacted] |
| 68 | [redacted] | [redacted] |
| 69 | [redacted] | [redacted] |
| 70 | [redacted] | [redacted] |
| 71 | [redacted] | [redacted] |
| 72 | [redacted] | [redacted] |
| 73 | [redacted] | [redacted] |
4
| Age | Male Annuitants | Female Annuitants |
|---|---|---|
| 74 | [redacted] | [redacted] |
| 75 | [redacted] | [redacted] |
| 76 | [redacted] | [redacted] |
| 77 | [redacted] | [redacted] |
| 78 | [redacted] | [redacted] |
| 79 | [redacted] | [redacted] |
| 80 | [redacted] | [redacted] |
| 81 | [redacted] | [redacted] |
| 82 | [redacted] | [redacted] |
| 83 | [redacted] | [redacted] |
| 84 | [redacted] | [redacted] |
| 85 | [redacted] | [redacted] |
| 86 | [redacted] | [redacted] |
| 87 | [redacted] | [redacted] |
| 88 | [redacted] | [redacted] |
| 89 | [redacted] | [redacted] |
| 90 | [redacted] | [redacted] |
| 91 | [redacted] | [redacted] |
| 92 | [redacted] | [redacted] |
| 93 | [redacted] | [redacted] |
| 94 | [redacted] | [redacted] |
| 95 | [redacted] | [redacted] |
| 96 | [redacted] | [redacted] |
| 97 | [redacted] | [redacted] |
| 98 | [redacted] | [redacted] |
| 99 | [redacted] | [redacted] |
| 100 | [redacted] | [redacted] |
| 101 | [redacted] | [redacted] |
| 102 | [redacted] | [redacted] |
| 103 | [redacted] | [redacted] |
| 104 | [redacted] | [redacted] |
| 105 | [redacted] | [redacted] |
| 106 | [redacted] | [redacted] |
| 107 | [redacted] | [redacted] |
| 108 | [redacted] | [redacted] |
| 109 | [redacted] | [redacted] |
| 110 | [redacted] | [redacted] |
| 111 | [redacted] | [redacted] |
| 112 | [redacted] | [redacted] |
| 113 | [redacted] | [redacted] |
| 114 | [redacted] | [redacted] |
5
| Age | Male Annuitants | Female Annuitants |
|---|---|---|
| 115 | [redacted] | [redacted] |
| 116 | [redacted] | [redacted] |
| 117 | [redacted] | [redacted] |
| 118 | [redacted] | [redacted] |
| 119 | [redacted] | [redacted] |
| 120 | [redacted] | [redacted] |
The above rates were developed based on an experience study period from January 1,
[redacted] through December 31, [redacted], with a base year of [redacted]. The rates were calculated
by adjusting the applicable standard mortality tables in section 1.430(h)(3)-1(d) of the
Regulations, using the mortality ratio and credibility weighting factor determined by
aggregating male and female experience, as shown in the table below.
| Combined Male and Female Annuitants | |
|---|---|
| Mortality ratio | [redacted] |
| Credibility Weighting Factor | [redacted] |
The Internal Revenue Service has reviewed the substitute mortality rates and
supporting information, and has determined that based on the information submitted,
the rates were developed in accordance with section 1.430(h)(3)-2 of the Regulations
and Revenue Procedure 2017-55.
The above rates must be applied on a generational basis, as provided in section
1.430(h)(3)-2(c)(3) of the Regulations.
Your attention is called to section 430(h)(3)(C)(ii) of the Code and section 1.430(h)(3)-
2(c)(6) of the Regulations, which describe the circumstances in which the use of the
substitute mortality table will terminate before the end of the 5-year period described
above. In general, the substitute mortality tables can no longer be used as of the
earliest of:
(1) For a plan using a substitute mortality table for only one gender, the first plan
year for which there is full or partial credible mortality information with respect to
the other gender that had lacked credible mortality information (unless an
approved substitute mortality table is used for that gender),
(2) The first plan year in which the plan fails to satisfy the requirements of section
1.430(h)(3)-2(c)(1) of the Regulations, regarding the requirement that other
plans and populations in the controlled group must also use substitute mortality
tables unless it can be demonstrated that they do not have credible mortality
information (taking into account the transition period for newly affiliated
companies in section 1.430(h)(3)-2(f)(3) of the Regulations),
6
(3) The second plan year following the plan year for which there is a significant
change in individuals covered by the plan as described in section
1.430(h)(3)-2(c)(6)(iii) of the Regulations,
(4) The plan year following the plan year in which a substitute mortality table used
for a plan population is no longer accurately predictive of future mortality of that
population, as determined by the Commissioner or as certified by the plan's
actuary to the satisfaction of the Commissioner, or
(5) The date specified in guidance published in the Internal Revenue Bulletin
pursuant to a replacement of mortality tables specified under section
430(h)(3)(A) of the Code and section 1.430(h)(3)-1 of the Regulations, other
than annual updates to the static mortality tables issued pursuant to section
1.430(h)(3)-1(a)(3) of the Regulations or changes to the mortality improvement
rates pursuant to section 1.430(h)(3)-1(a)(2)(i)(C) of the Regulations.
We draw your attention to the fact that the nonannuitants experienced [redacted] deaths during
the experience study period. Note that this population will have credible mortality
experience if it experiences at least [redacted] deaths during a [redacted]-year period (corresponding to
the length of the experience study used to construct the substitute mortality tables for
the other populations). It is important to monitor this population to ensure that
appropriate action is taken should this occur, to avoid violating paragraph (2) above.
Also note that section 1.430(h)(3)-2(c)(6)(iii) provides that the use of substitute mortality
tables must be discontinued after a significant change in coverage unless the plan's
actuary certifies in writing to the satisfaction of the Commissioner that the substitute
mortality tables used for the population continue to be accurately predictive of future
mortality of the population (taking into account the effect of the change in the
population). For this purpose, a significant change in coverage occurs if the number of
individuals covered by the substitute mortality table for a plan year is less than 80
percent or more than 120 percent of either (1) the average number of individuals in that
population over the years covered by the experience study on which the substitute
mortality table is based, or (2) the number of individuals covered by the substitute
mortality table in a plan year for which a certification described in section 1.430(h)(3)-
2(c)(6)(iii)(A) of the Regulations was made.
For reference, the average number of the male and female annuitants of the Plan over
the years covered by the experience study, as well as the most recent number of male
and female annuitants in the submission, are as follows:
| Male and Female Annuitants (excluding disabled annuitants) | |
|---|---|
| Average during the experience study period | [redacted] |
| Most recent data in the submission | [redacted] |
7
A certification must be provided each year that it is required under the Regulations, as
described above, signed by the enrolled actuary for the plan and stating that the
substitute mortality tables continue to be accurately predictive of the expected future
mortality for the plan. The certification must also contain a statement that:
a. The enrolled actuary is current with educational requirements set forth by the
Joint Board for the Enrollment of Actuaries as well as any other actuarial
designations asserted;
b. The enrolled actuary was personally involved in the determination that the
substitute mortality table is still accurately predictive and provides the
actuary’s best estimate for the Plan;
c. In determining that the substitute mortality table is still accurately predictive,
the enrolled actuary took into consideration the effect of business
combinations, plan mergers or spinoffs and settlements/other risk transfers,
and other events that would have similar effects on the relevant populations;
and;
d. The enrolled actuary has the specific knowledge and experience to make the
judgements set forth above and attests to these representations.
All required certifications must be provided on or before the date Form 5500 is filed for
each plan year for which the certification is required and must be accompanied by the
supporting information relied upon by the enrolled actuary to make that certification. To
the extent possible, please also provide the following supporting information:
(1) The number of actual deaths during the experience study period used to develop
the substitute mortality tables and the beginning and ending dates of the
experience study period.
(2) A table showing the number of expected deaths and actual deaths, reported
separately for each plan year beginning with deaths during the plan year ending
December 31, [redacted] through the plan year immediately preceding the most
recent actuarial valuation, and in total.
(3) A table similar to the stability demonstration required under section 8 of
Revenue Procedure 2017-55, showing the average number of participants in the
population covered by the substitute mortality tables during the experience study
period and the number of participants in that population as of the end of each
8
plan year, beginning with December 31, 2018 through the plan year immediately
preceding the most recent actuarial valuation, expressed both as a headcount
and as a percentage of the average number of participants in the experience
study.
(4) A table showing a comparison of (i) the average ages and (ii) percentage of the
population, by the following monthly single life annuity brackets: under $[redacted],
between $[redacted] and $[redacted], between $[redacted] to $[redacted], between $[redacted] to $[redacted],
between $[redacted] and $[redacted], and $[redacted] and over, along with the average age
and average benefit amount for the population in total. This information should
be provided for the population in the experience study and at the end of each
plan year, beginning with the valuation date for the first plan year that the
certification is required, through the date immediately preceding the most recent
actuarial valuation at the time the information is reported.
(5) An explanation of any material changes in the population.
This information must be provided to David M. Ziegler (or to another individual
designated by the Service), by fax at (202) 317-8811, or to the following address:
Internal Revenue Service
Attn: Mr. David M. Ziegler
TE/GE: SE:T:EP:RA:T:A2
NCA-630
1111 Constitution Ave. NW
Washington DC 20224-0002
Failure to provide this information by the due date may result in a requirement that the
standard mortality tables must be used for purposes of section 430 of the Code,
beginning with the earlier of (1) the plan year for which the deadline for providing this
information is missed or (2) the date required for early termination of the use of the
substitute mortality tables pursuant to section 1.430(h)(3)-2(c)(6)(ii) of the Regulations.
This ruling is directed only to the taxpayer that requested it. Section 6110(k)(3) of the
Code provides that it may not be used or cited by others as precedent.
When filing Form 5500 for the plan years for which the substitute mortality tables are
used, please note the information that is required to be attached to Schedule SB
(Actuarial Information) in accordance with the instructions to that form.
We have sent a copy of this letter to your authorized representative pursuant to a power
of attorney on file in this office and to the Manager, EP Classification in Columbus, Ohio
and to the Manager, EP Compliance Unit in Chicago, Illinois.
9
If you require further assistance in this matter, please contact [redacted]
(ID# [redacted]) at ([redacted]) [redacted].
Sincerely,
David M. Ziegler, Manager
Employee Plans Actuarial Group 2
Attachments
Notice 437 — Notice of Intention to Disclose
Copy of ruling letter with proposed deletions
cc:
Get today's answer for your situation
You just read what the IRS ruled for one taxpayer in 2021, and it can't be cited as precedent. Ezel checks the current Internal Revenue Code and IRS guidance and answers your specific situation, with citations.
Opens in Ezel Pro. Every answer cites the authority it relies on.